Effectiveness of TNFi versus Non-TNFi Biologics on Disease Activity in Obese Patients with Rheumatoid Arthritis: Data from the ACR's RISE Registry

被引:0
|
作者
Gianfrancesco, Milena [1 ]
Li, Jing [1 ]
Ja, Clairissa [2 ]
Seet, Andrea [1 ]
Schmajuk, Gabriela [1 ]
Yazdany, Jinoos [1 ]
机构
[1] Univ Calif San Francisco, San Francisco, CA USA
[2] Univ Calif Davis, San Francisco, CA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
0588
引用
收藏
页码:1193 / 1194
页数:2
相关论文
共 50 条
  • [41] DOMAINS IMPACTING MINIMAL DISEASE ACTIVITY NON-ACHIEVEMENT IN PATIENTS WITH PSORIATIC ARTHRITIS AND INADEQUATE RESPONSE TO TNFI RECEIVING GUSELKUMAB (COSMOS)
    Coates, L.
    Selmi, C.
    Schett, G.
    Richette, P.
    Ramirez, J.
    Noel, W.
    Rampakakis, E.
    Zimmermann, M.
    Sharaf, M.
    Mcgonagle, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1126 - 1127
  • [42] Time to rebound in joint symptoms following discontinuation of TNFi therapy after achieving low disease activity in psoriatic arthritis patients enrolled in the US Corrona Registry
    Harrold, Leslie R.
    Stolshek, Brad
    Rebello, Sabrina
    Collier, David
    Mutebi, Alex
    Wade, Sally W.
    Greenberg, Jeffery D.
    Etzel, Carol J.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB260 - AB260
  • [43] THE RELATIONSHIP BETWEEN DISEASE ACTIVITY AND FINANCIAL TOXICITY IN PATIENTS WITH RHEUMATOID ARTHRITIS ON BIOLOGICS: A CROSS-SECTIONAL STUDY USING THE JAPANESE RHEUMATOID ARTHRITIS REGISTRY
    Inoue, R.
    Yajima, N.
    Matsui, T.
    Tohma, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 575 - 576
  • [44] DISEASE ACTIVITY TRAJECTORIES FOR EARLY AND ESTABLISHED RHEUMATOID ARTHRITIS: DATA FROM THE OBRI REGISTRY
    Movahedi, M.
    Cesta, A.
    Li, X.
    Bombardier, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 594 - 594
  • [45] TIME TO REBOUND IN JOINT SYMPTOMS FOLLOWING DISCONTINUATION OF TNFI THERAPY AFTER ACHIEVING LOW DISEASE ACTIVITY OR REMISSION IN PSORIATIC ARTHRITIS PATIENTS ENROLLED IN THE US CORRONA REGISTRY
    Harrold, L. R.
    Stolshek, B.
    Rebello, S.
    Collier, D.
    Mutebi, A.
    Wade, S. W.
    Malley, W.
    Greenberg, J. D.
    Etzel, C. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 342 - 343
  • [46] PERSISTENCE ON TUMOUR NECROSIS FACTOR INHIBITOR (TNFI) MONOTHERAPY AFTER ACHIEVING REMISSION OR LOW DISEASE ACTIVITY (LDA) ON COMBINATION THERAPY AMONG PATIENTS WITH RHEUMATOID ARTHRITIS (RA)
    Pappas, D. A.
    Litman, H. J.
    Lesperance, T.
    Rebello, S.
    Karis, E.
    Kricorian, G.
    Hua, W.
    Accortt, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 600 - 601
  • [47] EFFICACY OF MONOTHERAPY OF THE BIOLOGIC DMARDS IN PATIENTS WITH RHEUMATOID ARTHRITIS: REAL LIFE DATA FROM THE HONG KONG BIOLOGICS REGISTRY
    Mok, C. C.
    Wan, R.
    Fong, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1376 - 1376
  • [48] Efficacy of Monotherapy of the Biologic Dmards in Patients with Rheumatoid Arthritis: Real Life Data from the Hong Kong Biologics Registry
    Mok, Chi Chiu
    Wan, Ting Hung
    Fong, Lai Shan
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [49] Interstitial Lung Disease in Patients With Rheumatoid Arthritis or Psoriatic Arthritis Initiating Biologics and Controls: Data From 5 Nordic
    Provan, Sella Aarrestad
    Ljung, Lotta
    Kristianslund, Eirik Klami
    Michelsen, Brigitte
    Uhlig, Till
    Jonmundsson, Thorarinn
    Sexton, Joe
    Gudbjornsson, Bjorn
    Di Giuseppe, Daniela
    Hetland, Merete Lund
    Reynisdottir, Gudrun Bjork
    Glintborg, Bente
    Relas, Heikki
    Aaltonen, Kalle
    Kvien, Tore Kristian
    Askling, Johan
    JOURNAL OF RHEUMATOLOGY, 2024, 51 (11) : 1111 - 1118
  • [50] Thresholds in disease activity for switching biologics in rheumatoid arthritis patients: Experience from a large US cohort
    Zhang, Jie
    Shan, Ying
    Reed, George
    Kremer, Joel
    Greenberg, Jeffrey D.
    Baumgartner, Scott
    Curtis, Jeffrey R.
    ARTHRITIS CARE & RESEARCH, 2011, 63 (12) : 1672 - 1679